Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The biosimilar regulatory pathway

Paul Cornes • 21 Mar 2017

How is the use of a biosimilar approved? What do regulators look for? How do they guarantee their safety? Paul Cornes, MD from the University Hospital Bristol NHS Foundation Trust, Bristol, UK talks about the biosimilars regulatory pathway.

More from Paul Cornes

4:16
Can a epoetin biosimilar be used to treat chemotherapy-induced anemia?
Paul Cornes • 22 Jun 2017
2:24
Are biosimilars as efficacious as their reference drugs?
Paul Cornes • 22 Jun 2017
1:21
Explaining biosimilars to our patients
Paul Cornes • 27 Jun 2017
3:56
Can the dream of affordable cancer care come true?
Paul Cornes • 21 Mar 2017
The content of VJHemOnc is intended for healthcare professionals